Skip to content

Search

What is diabetes

Type 1 diabetes is a chronic autoimmune disease that results from the immune system attacking the insulin-producing cells of the pancreas. Unlike type 2 diabetes which is potentially preventable, type 1 is a non-preventable disease - currently, its exact cause is not known and there is no cure.

Our team

The JDRF Global Centre of Excellence is being driven by two of Australia’s leading diabetes researchers and clinicians, Professors Liz Davis and Tim Jones based at The Kids Research Institute Australia and Perth Children’s Hospital.

Kids have a 'wild' time at diabetes camp

Kids living with type 1 diabetes got to hang out with peers and have a lot of fun at the Diabetes WA and Perth Children’s Hospital kids’ camp in Bicton recently.

Ads clinic update

The Perth Children’s Hospital (PCH) Adolescent Diabetes Service (ADS) clinics have had several updates thanks to your feedback, including the introduction of “Welcome to Ads group sessions” for teenagers.

Made with love

When two-year-old Clara first went onto the new Ypso HCL system, her mum Sarah found that the pump belt was just a little too big for her.

Congratulations Seed Funding Recipients!

The Rio Tinto Children’s Diabetes Centre; a JDRF Global Centre of Excellence announces inaugural funding for researchers dedicated to type 1 diabetes.

Being active is key to heart health

Did you know that regular exercise can literally add years to the lives of children living with Type 1 Diabetes?

Good news for students

The Children’s Diabetes Centre welcomes a new Federal Government initiative to support children with Type 1 Diabetes in schools. The two-year $6 million schools education and training program will be implemented at every school with a student with Type 1 Diabetes.

New research on youth-onset type 2 diabetes in northern Australia

Explore new research on youth-onset diabetes at The Kids' Institute, uncovering insights to improve health outcomes for young patients in Northern Australia.

Aussies publish first RCT of hybrid closed loop systems

A world-first clinical trial has shown young people with type 1 diabetes have better glycaemic control and quality of life while on hybrid closed loop (HCL) systems versus conventional treatments, Australian endocrinologists say.